Literature DB >> 9725480

Biopharmaceutical evaluation of time-controlled press-coated tablets containing polymers to adjust drug release.

M Halsas1, P Ervasti, P Veski, H Jürjenson, M Marvola.   

Abstract

This paper deals with press-coated modified release tablets in which the drug dose is situated in the core or is divided between the core and the coat. The coat contains polymer (sodium alginate or hydroxypropylmethyl cellulose, HPMC) to control drug release. The main objective was to investigate how the pharmacokinetic profile of the model drug could be modified by altering the proportion of the drug between the core and the coat. The effect of the amount of the polymer in the coat was also studied. Bioavailability tests were carried out on healthy volunteers. In the absorption curves of the tablets containing 50%, 67% and 80% of the drug in the core and 180 mg HPMC in the coat a bimodal profile was observed. No bimodal release pattern in the in vitro dissolution studies was found. If the whole dose was incorporated in the core the absorption curve has only one clear t(max) value at about 10 h. Doubling the amount of HPMC in the coat dramatically decreased drug absorption. It was concluded that, if a slightly reduced t(max)-value was required, the viscosity grade of HPMC used should be lowered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725480     DOI: 10.1007/BF03189338

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  2 in total

1.  High-performance liquid chromatographic determination of ibuprofen in human plasma and urine by direct injection.

Authors:  A Avgerinos; A J Hutt
Journal:  J Chromatogr       Date:  1986-08-02

Review 2.  Biological rhythms in the inflammatory response and in the effects of non-steroidal anti-inflammatory drugs.

Authors:  G Labrecque; J P Bureau; A E Reinberg
Journal:  Pharmacol Ther       Date:  1995-05       Impact factor: 12.310

  2 in total
  1 in total

1.  Use of in vitro-in vivo correlation to predict the pharmacokinetics of several products containing a BCS class 1 drug in extended release matrices.

Authors:  Tahseen Mirza; Srikant A Bykadi; Christopher D Ellison; Yongsheng Yang; Barbara M Davit; Mansoor A Khan
Journal:  Pharm Res       Date:  2012-08-22       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.